MedTrace Logo

Predicting Tolerance to Radiation Therapy in Older Adults With Cancer

NCT01752751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-06-04

No results posted yet for this study

Summary

A comprehensive geriatric assessment tool developed by Hurria and colleagues has been used in non-radiation oncology clinical settings to predict how older adults tolerate cancer treatments. The investigators think this same tool (referred to as the CGA) can be used in a radiation oncology clinic to predict for poor treatment tolerance.

Conditions

  • Pre-treatment Loss of Independent Activities of Daily Living

Sponsors & Collaborators

  • Alpha Omega Alpha Honor Medical Society

    collaborator UNKNOWN

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Bhishamjit Chera, MD · Radiation Oncology UNC Cancer Hospital

  • Noam VanderWalde, MD · Radiation Oncology UNC Cancer Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01752751 on ClinicalTrials.gov